Item 16. Form 10-K Summary

Not applicable.

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Eli Lilly and Company


By						/s/ David Ricks
David Ricks
Chair, President, and Chief Executive Officer

February 19, 2025

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below on February 19, 2025 by the following persons on behalf of the Registrant and in the capacities indicated.


Signature						Title

/s/ David Ricks						Chair, President, and Chief Executive Officer (principal executive officer)
DAVID RICKS

/s/ Lucas Montarce						Executive Vice President and Chief Financial Officer (principal financial officer)
LUCAS MONTARCE

/s/ Donald Zakrowski						Senior Vice President, Finance, and Chief Accounting Officer (principal accounting officer)
DONALD ZAKROWSKI

/s/ Ralph Alvarez						Director
RALPH ALVAREZ

/s/ Katherine Baicker, Ph.D.						Director
KATHERINE BAICKER, Ph.D.

/s/ Erik Fyrwald						Director
ERIK FYRWALD

/s/ Mary Lynne Hedley, Ph.D.						Director
MARY LYNNE HEDLEY, Ph. D.

/s/ Jamere Jackson						Director
JAMERE JACKSON

/s/ Kimberly Johnson						Director
KIMBERLY JOHNSON

/s/ William Kaelin, Jr., M.D.						Director
WILLIAM KAELIN, JR., M.D.

/s/ Juan Luciano						Director
JUAN LUCIANO

/s/ Jon Moeller						Director
JON MOELLER

/s/ Gabrielle Sulzberger						Director
GABRIELLE SULZBERGER

Previous: Item 15. Exhibits and Financial Statement Schedules